Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 281 M304 M300 M334 M378 M 1.32 B Research & development ————— — Operating income 247 M848 M825 M274 M1.04 B 2.99 B Non-Operating Income, Total 37 M30 M23 M21 M20 M 94 M Interest expense, net of interest capitalized 51 M49 M38 M32 M39 M 158 M Non-Operating Income, excl. Interest Expenses -14 M-19 M-15 M-11 M-19 M -64 M Unusual income/expense ————— — Pretax income 285 M899 M883 M501 M1.1 B 3.38 B Equity in earnings 4 M10 M10 M11 M7 M 38 M Taxes 59 M193 M200 M78 M226 M 697 M Non-controlling/minority interest 70 M103 M76 M45 M127 M 351 M After tax other income/expense ————— — Net income before discontinued operations 156 M603 M607 M378 M743 M 2.33 B Discontinued operations ————— — Net income 156 M603 M607 M378 M743 M 2.33 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 156 M600 M605 M376 M740 M 2.32 B Basic earnings per share (Basic EPS) 0.672.62.631.633.23 10.09 Diluted earnings per share (Diluted EPS) 0.672.62.631.623.23 10.08 Average basic shares outstanding 232.7 M230.6 M229.9 M230.7 M228.9 M — Diluted shares outstanding 232.9 M230.8 M230.2 M231 M229.3 M — EBITDA 615 M1.21 B1.19 B653 M1.43 B 4.49 B EBIT 247 M848 M825 M274 M1.04 B 2.99 B Cost of revenue 7.22 B7.23 B7.33 B6.83 B8 B 29.39 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 368 M366 M367 M379 M384 M 1.5 B